These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 32614875)

  • 21. Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening.
    Lindell M; Sanner K; Wikström I; Wilander E
    BJOG; 2012 Jan; 119(2):245-8. PubMed ID: 22017806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
    Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
    BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
    Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
    PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women.
    Bosgraaf RP; Ketelaars PJ; Verhoef VM; Massuger LF; Meijer CJ; Melchers WJ; Bekkers RL
    Prev Med; 2014 Jul; 64():108-13. PubMed ID: 24736093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
    BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône].
    Piana L; Leandri FX; Le Retraite L; Heid P; Tamalet C; Sancho-Garnier H
    Bull Cancer; 2011 Jul; 98(7):723-31. PubMed ID: 21700548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 30. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
    Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening.
    Cadman L; Wilkes S; Mansour D; Austin J; Ashdown-Barr L; Edwards R; Kleeman M; Szarewski A
    J Med Screen; 2015 Mar; 22(1):28-37. PubMed ID: 25403717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
    Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
    Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
    BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
    Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
    Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 40. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.